Skip To Main Content
Barry J.A on Muck Rack

Barry J.A

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Barry

Contact Barry, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Global Leadership Initiative on Malnutrition cachexia: an inflammation-first approach for the diagnosis of disease-related malnutrition

|
By Richard J.E, Barry J.A
| gla.ac.uk
McGovern, J., Skipworth, R. J.E., Laird, B. J.A. and McMillan, D. C. (2024) Global Leadership Initiative on Malnutrition cachexia: an inflammation-first approach for the diagnosis of disease-related malnutrition. Current Opinion in Clinical Nutrition and Metabolic Care, 27(5), pp. 393-396. (doi: 10.1097/mco.0000000000001052) (PMID:39110108) Full text not currently available from Enlighten.
Open in Who Shared Issue with article?

Biomarker endpoints in cancer cachexia clinical trials: Systematic Review 5 of the cachexia endpoint series

|
By Richard J.E, Ola Magne, Barry J.A
| gla.ac.uk
Yule, M. S. et al. (2024) Biomarker endpoints in cancer cachexia clinical trials: Systematic Review 5 of the cachexia endpoint series. Journal of Cachexia, Sarcopenia and Muscle, 15(3), pp. 853-867. (doi: 10.1002/jcsm.13491) (PMID:38783477) (PMCID:PMC11154797) Text 328520.pdf - Published Version Available under License Creative Commons Attribution. 733kB Abstract Regulatory agencies require evidence that endpoints correlate with clinical benefit before they can be used to approve drugs.
Open in Who Shared Issue with article?

Results from a randomised, open-label trial of a multimodal intervention (exercise, nutrition and anti-inflammatory medication) plus standard care versus standard care alone to attenuate cachexia in patients with advanced cancer undergoing chemotherapy.

|
By Barry J.A, Andrew Kim. Eugene, Martin Robert, Guro Birgitte
| gla.ac.uk
Solheim, T. S. et al. (2024) Results from a randomised, open-label trial of a multimodal intervention (exercise, nutrition and anti-inflammatory medication) plus standard care versus standard care alone to attenuate cachexia in patients with advanced cancer undergoing chemotherapy. 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, Chicago, Illinois, USA, 31 May-04 June 2024. (doi: 10.1200/jco.2024.42.17_suppl.lba12007) Full text not currently available from Enlighten.
Open in Who Shared Issue with article?
See all 5 articles